Showing results (171-180 of 309) with videos related to

Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder CancerAnastasios D Asimakopoulos, Maxim Kochergin, Gaia Colalillo, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Outcomes of Patients with Bacillus Calmette-Guérin (BCG)-Unresponsive Non-Muscle Invasive Bladder Cancer as Defined by the U.S. Food and Drug AdministrationJeffrey M Howard, Grayden S Cook, Aaron Tverye, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Impact of Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Population Based AnalysisSiv Venkat, Patrick J Lewicki, Spyridon P Basourakos, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Impact of Intestinal Urinary Diversion on the Risk of Fracture and Loss of Bone Mass: A Systematic ReviewCarmen Pozo, Benjamin Pradere, Katharina Rebhan, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized DiseaseJulia Slotta-Huspenina, Kristina Schwamborn, Katja Steiger, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Identification of a Novel Ferroptosis-Related Gene Signature for Prediction of Prognosis in Bladder Urothelial CarcinomaXiaokai Shi, Xiao Zhou, Lei Zhang, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Erratum: Challenging Cases in Urothelial CancerMark S Soloway, Neil A Abrahams
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide StudyStaffan Jahnson, Truls Gårdmark, Abolfazl Hosseini, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial CarcinomaPetros Grivas, Lesli A Kiedrowski, Guru P Sonpavde, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based ModelMichael L Creswell, Tamir N Sholklapper, Michael J Markel, et al.
Pageof 31